XOMA

XOMA is a biotechnology royalty aggregator that acquires economic rights to future milestone, royalty, and commercial payments tied to partnered therapeutic assets. Its revenue is primarily generated from royalty receipts, milestone payments, and other monetization of intellectual property and partnered drug programs.

Relationship details are part of the Pro plan.